Table 8. Comparison of the measles, mumps, rubella, and varicella-zoster seropositivity with previous study findings in the Republic of Korea.
| Antibodies | Research period | Occupation | Age | Sex | Seropositivity (%) | Yeara | Reference |
|---|---|---|---|---|---|---|---|
| Measles | 2011–2019 | New nurses | 21–40 | F | 551/587 (93.9) | 2021 | This study |
| 2019 | HCW | - | All | 2,636/2,830 (93.1) | 2019 | Kwak et al.20 | |
| 2014–2018 | HCW | - | All | 5,410/7,411 (73.0) | 2019 | Jung et al.21 | |
| 2019 | HCW | - | All | 6,935/9,132 (75.9) | 2019 | Chang et al.22 | |
| - | GP | 2–18 | All | 1,095/1,400 (74.2) | 2012 | Kim et al.23 | |
| Mumps | 2011–2019 | New nurses | 21–40 | F | 50/83 (60.2) | 2021 | This study |
| 2018 | HCW | - | All | 5,287/6,055 (87.3) | 2020 | Kim et al.24 | |
| Rubella | 2011–2019 | New nurses | 21–40 | F | 3,093/3,711 (83.3) | 2021 | This study |
| 2010–2017 | GP | 15–49 | F | 300,156/328,426 (76.4) | 2020 | Choi et al.25 | |
| 2004–2018 | GP | 20–49 | F | 69,181/72,114 (95.9) | 2020 | Choe et al.26 | |
| Varicella-zoster | 2011–2019 | New nurses | 21–40 | F | 978/1,093 (89.5) | 2021 | This study |
| 2012–2013 | GP | 10 ≤ | All | 1,114/1,196 (99.1) | 2015 | Han et al.27 | |
| 2018 | HCW | 21–56 | All | 526/550 (96.0) | 2014 | Kang et al.28 | |
| 2009–2010 | GP | 0–79 | All | 1,117/1,302 (85.8) | 2013 | Lee et al.29 | |
| 2008 | GP | - | All | 777/887 (87.6) | 2010 | Choi et al.30 |
GP, general population; HCW, health care workers.
aYear of publication.